glucose, (beta-d)-isomer has been researched along with phentermine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
le Roux, CW; Miras, AD | 1 |
Aronne, LJ; Mauer, EA; Rathi, S; Shukla, AP; Thomas, CE | 1 |
Bellanger, D; Chappell, N; Elkind-Hirsch, KE; Seidemann, E; Storment, J | 1 |
1 review(s) available for glucose, (beta-d)-isomer and phentermine
Article | Year |
---|---|
Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?
Topics: Anti-Obesity Agents; Bariatric Surgery; Benzazepines; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Type 2; Exercise; Feeding Behavior; Female; Fructose; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Homeostasis; Humans; Islet Amyloid Polypeptide; Lactones; Male; Minimally Invasive Surgical Procedures; Obesity, Morbid; Orlistat; Phentermine; Receptors, Glucagon; Topiramate; Treatment Outcome; Weight Loss | 2014 |
1 trial(s) available for glucose, (beta-d)-isomer and phentermine
Article | Year |
---|---|
Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Benzhydryl Compounds; Blood Glucose; Drug Therapy, Combination; Exenatide; Female; Glucose Tolerance Test; Glucosides; Humans; Hypoglycemic Agents; Metformin; Middle Aged; Obesity; Phentermine; Polycystic Ovary Syndrome; Prospective Studies; Single-Blind Method; Topiramate; Treatment Outcome; Weight Loss; Young Adult | 2021 |
1 other study(ies) available for glucose, (beta-d)-isomer and phentermine
Article | Year |
---|---|
Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.
Topics: Anti-Obesity Agents; Benzhydryl Compounds; Databases, Factual; Drug Prescriptions; Glucosides; Humans; Hypoglycemic Agents; Obesity; Phentermine; Practice Patterns, Physicians'; Retrospective Studies; United States; Weight Loss | 2016 |